MedPath

Remifentanila influence on management control in intravenous Anesthesia.

Not Applicable
Conditions
Anesthesiology, hypnosis, propofol, opioids, signs and symptoms.
E02.190.525.217
H02.403.066
D02.455.426.559.389.657.773
D27.505.696.277.600.500
Registration Number
RBR-555htm
Lead Sponsor
Centro Médico de Campinas
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruitment completed
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

They will be included in this study patients enrolled in the pre-anesthetic evaluation office of Campinas Medical Center Foundation; with surgical risk level 1 and 2 (which are lower risk); aged between 18 and 65 years.

Exclusion Criteria

illicit drugs and allergies to any medication used in this study

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath